Shares of LivaNova PLC (NASDAQ:LIVN) have been assigned a consensus recommendation of “Hold” from the eight brokerages that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating, three have issued a hold rating and four have assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $71.50.

A number of equities research analysts recently commented on the company. Berenberg Bank reiterated a “buy” rating and issued a $70.00 price objective on shares of LivaNova PLC in a report on Friday, August 11th. Needham & Company LLC assumed coverage on LivaNova PLC in a report on Wednesday, August 23rd. They issued a “hold” rating for the company. Canaccord Genuity reiterated a “hold” rating and issued a $71.00 price objective on shares of LivaNova PLC in a report on Wednesday, September 20th. WBB Securities downgraded LivaNova PLC from a “hold” rating to a “sell” rating and set a $50.00 price objective for the company. in a report on Tuesday, August 15th. Finally, BidaskClub downgraded LivaNova PLC from a “buy” rating to a “hold” rating in a report on Tuesday, August 1st.

LivaNova PLC (NASDAQ LIVN) opened at 75.40 on Thursday. The firm has a market cap of $3.68 billion, a price-to-earnings ratio of 134.64 and a beta of 0.59. The company has a 50 day moving average price of $67.61 and a 200-day moving average price of $60.41. LivaNova PLC has a 52-week low of $40.83 and a 52-week high of $75.73.

LivaNova PLC (NASDAQ:LIVN) last released its quarterly earnings data on Wednesday, August 9th. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.82 by $0.19. The business had revenue of $321.40 million during the quarter, compared to the consensus estimate of $315.75 million. LivaNova PLC had a return on equity of 9.08% and a net margin of 2.26%. The company’s quarterly revenue was up .1% compared to the same quarter last year. Equities research analysts anticipate that LivaNova PLC will post $3.25 EPS for the current year.

In other LivaNova PLC news, Director Daniel Jeffrey Moore sold 1,000 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $68.55, for a total value of $68,550.00. Following the completion of the transaction, the director now directly owns 57,296 shares of the company’s stock, valued at $3,927,640.80. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Over the last three months, insiders sold 3,000 shares of company stock valued at $190,860. Insiders own 0.28% of the company’s stock.

A number of large investors have recently bought and sold shares of the business. PNC Financial Services Group Inc. grew its stake in LivaNova PLC by 9.8% in the second quarter. PNC Financial Services Group Inc. now owns 1,707 shares of the company’s stock valued at $105,000 after acquiring an additional 153 shares during the period. Advantus Capital Management Inc grew its stake in LivaNova PLC by 3.3% in the first quarter. Advantus Capital Management Inc now owns 5,551 shares of the company’s stock valued at $272,000 after acquiring an additional 176 shares during the period. Liberty Mutual Group Asset Management Inc. grew its stake in LivaNova PLC by 1.1% in the first quarter. Liberty Mutual Group Asset Management Inc. now owns 19,529 shares of the company’s stock valued at $957,000 after acquiring an additional 206 shares during the period. Texas Permanent School Fund grew its stake in LivaNova PLC by 0.8% in the second quarter. Texas Permanent School Fund now owns 31,658 shares of the company’s stock valued at $1,938,000 after acquiring an additional 265 shares during the period. Finally, State Treasurer State of Michigan grew its stake in LivaNova PLC by 1.7% in the second quarter. State Treasurer State of Michigan now owns 17,900 shares of the company’s stock valued at $1,096,000 after acquiring an additional 300 shares during the period. 82.25% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: This news story was reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States and international trademark and copyright laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2017/10/12/livanova-plc-livn-given-average-recommendation-of-hold-by-brokerages.html.

LivaNova PLC Company Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Analyst Recommendations for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.